Column | Value-Based Payment

Value: The Way Forward

Column | Value-Based Payment

Value: The Way Forward

Value-based payment won’t bend the cost curve unless healthcare organizations commit to fundamental change. Not everyone will come out whole. 

New research finds that value-based payment models have yet to curb growth in the total cost of care. What, then, is the way forward?

A study to be published by HFMA in May found no correlation between population-based value-based payment (VBP) models and total cost of care. Furthermore, a higher level of VBP model penetration had no statistically significant impact on quality outcomes. In this study—which was conducted with support from the Commonwealth Fund—researchers from HFMA, Leavitt Partners, and McManis Consulting analyzed a variety of factors that may be influencing the total cost of care in healthcare markets across the nation. They found that a combination of factors can predict more than 80 percent of variations in baseline total cost of care across markets (with prevalence of chronic diseases having the most significant impact), but those factors explain only about 27 percent of variations in cost growth. Timing, misaligned incentives, and infrastructure investment requirements were identified as potential explanations for the lack of correlation between VBP penetration and cost and quality outcomes.

No doubt these factors come into play. But I suspect there is more to it. I believe that we, as an industry, have not fully come to terms with a sobering reality of the value era: Simply stated, we must change. Not just incremental change, or shifting cost from one level of care to another, or achieving cost savings that aren’t passed through to care purchasers, but real change—the kind that makes us uncomfortable.

If we truly want to reduce the rate of cost growth to the rate of inflation, change is needed on two levels. The first level is contractual. VBP contracts should be redesigned so that the parties involved have more “skin in the game.” VBP models that protect existing fee-for-service revenue streams, avoid downside risk, or don’t effectively address chronic conditions won’t get us where we need to go. VBP experimentation is not new anymore; the time for dipping our toes in the water is over if holding down healthcare inflation is truly important to us.

The second level of change is more fundamental. We must restructure provider and payer organizations in ways that allow organizations to operate at a margin in a value framework. No margin, no mission—it’s just as true in VBP as it is in fee for service. Here’s the part that’s hardest to accept: Not everyone will come out whole. The consolidation taking place in both the provider and payer sectors must ultimately reduce waste and duplication, rationalize service delivery, and integrate cost-saving technologies into the mainstream. Healthcare organizations will emerge from that process looking very different than they do today.

These will be among the greatest challenges most healthcare organizations have ever faced. But if we don’t take them on, the value transformation will stall as we continue to nibble around the edges of value. The window of opportunity for developing solutions as an industry, rather than having them imposed on us, is closing. The time to take ownership of the value challenge is now.


From the President's Desk


Joe Fifer expands on his ideas in his May column.

Follow Joe Fifer on Twitter: @HFMAFifer

About the Author

Joseph J. Fifer, FHFMA, CPA,

is President and CEO of HFMA.

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Value-Based Payment

Q&A | Cost Effectiveness of Health

Addressing U.S. healthcare system challenges requires a focus on improving health, not just care

If we are to effectively address the huge cost challenges facing the U.S. health system, we must begin to better address the cost effectiveness of health, says Todd Nelson, HFMA’s director of professional practice and partner relationships. And it has to be through a collaborative process involving all stakeholders, he says, including not just hospitals and health systems, physicians and health plans but also patients and their communities, as well as society overall.

News | Payment Models

Accountable care models will be almost universal for Medicare and Medicaid beneficiaries by 2030, CMS leaders say

A forthcoming revamp of federal value-based payment models will include features designed to encourage provider participation, CMS and CMMI leaders said.

News | Strategic Partnerships Mergers and Acquisitions

Healthcare M&A activity for Q3 remains low in volume but high in impact, firms report

The number of M&A transactions involving hospitals and health systems remained at historically low levels, but the average revenue involved was far higher than in recent years.

News | Strategic Planning

Consumerism and the transition to value are among the trends drawing strategic reactions from healthcare providers, survey finds

A recent survey finds healthcare providers working to ensure their strategic planning incorporates key trends, spurring innovations in care delivery models.